NCT02477995View on ClinicalTrials.gov

Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions

Pertussis

Interventions

BIOLOGICAL

DTaP Vaccine A

Adsorption tetanus-diphtheria-acellular pertussis (DTaP) Vaccine A(Bejing minhai Biological Co., LTD) of 0.5ml, three doses, 28 days interval

BIOLOGICAL

DTaP Vaccine B

Adsorption tetanus-diphtheria-acellular pertussis (DTaP) Vaccine B(Changchun changsheng Biological Co., LTD ) of 0.5ml in 600 infants aged 3-5months on day 0, 28, 56.

Trial Locations (1)

210009

Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing

All Listed Sponsors

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT02477995 - Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants | Biotech Hunter | Biotech Hunter